Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics
April 17 (UPI) — People diagnosed with type 2 diabetes might benefit soon from Eli Lilly’s new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker announced … Click to Continue »
View original article
Contributor:
